Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max S Topp

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Plos One|May 14, 2013
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78Leo Rasche, Johannes Duell, Charlotte Morgner, et al.
Blood|August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host diseaseClaudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvementMaximilian J Steinhardt, Franziska C Krummenast, Andreas Rosenwald, et al.
Annals of Hematology|January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 casesLeo Rasche, Corinna Bernard, Max S Topp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cellsEisei Kondo, Max S Topp, Hans-Peter Kiem, et al.
Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvementJan Diekmann, Eleni Adamopoulou, Olaf Beck, et al.
Blood|May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomabMax S Topp, Zachary Zimmerman, Paul Cannell, et al.
Annals of Hematology|October 4, 2016
Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemiaNiklas Vogt, Katharina Heß, Ralf Bialek, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Plos One|May 14, 2013
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78Leo Rasche, Johannes Duell, Charlotte Morgner, et al.
Blood|August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host diseaseClaudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvementMaximilian J Steinhardt, Franziska C Krummenast, Andreas Rosenwald, et al.
Annals of Hematology|January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 casesLeo Rasche, Corinna Bernard, Max S Topp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cellsEisei Kondo, Max S Topp, Hans-Peter Kiem, et al.
Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvementJan Diekmann, Eleni Adamopoulou, Olaf Beck, et al.
Blood|May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomabMax S Topp, Zachary Zimmerman, Paul Cannell, et al.
Annals of Hematology|October 4, 2016
Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemiaNiklas Vogt, Katharina Heß, Ralf Bialek, et al.
Pageof 13